# Clinical Feasibility of Mobile App-Based Self-Management for Breast Cancer-Related Lymphedema

> **NCT06922513** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 58 (actual)

## Conditions studied

- Breast Cancer Related Lymphedema

## Interventions

- **DEVICE:** digital health (Application and Smart Measuring Tape)

## Key facts

- **NCT ID:** NCT06922513
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-11
- **Primary completion:** 2025-10-21
- **Final completion:** 2025-10-21
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922513, "Clinical Feasibility of Mobile App-Based Self-Management for Breast Cancer-Related Lymphedema". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06922513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*